GCG and type 2 diabetes mellitus: Activating GLP‐1 receptors (GLP‐1Rs) in pancreatic islet cells can stimulate insulin secretion, increase β‐cell proliferation, reduce β‐cell apoptosis, and inhibit glucagon secretion in T2DM patients [51].